通过下一代测序识别新型HLA-C*14:159等位基因的鉴定
You-Keun Ko1, Jong Kwon Lee1, Sookyeon Lee1
1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
HLA
|March 25, 2024
概括
一个新的人类白细胞抗原 (HLA) 基因,HLA-C*14:159,被确定. 这一发现发生在等待移植的个体的标准HLA类型化程序中.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 移植科学 移植科学
背景情况:
- 人类白细胞抗原 (HLA) 排型对于成功的器官移植至关重要.
- HLA兼容性降低了移植拒绝的风险.
- HLA等位基因的多样性需要持续监测和识别.
研究的目的:
- 报告一种新的HLA等位基因的识别.
- 为了描述HLA-C*14:159等位基因的特征.
- 为移植HLA等位基因数据库做出贡献.
主要方法:
- 进行了常规的HLA类型检测.
- 使用了高分辨率的打字技术.
- 使用了基于序列的打字或类似的高分辨率方法.
主要成果:
- 检测到一个以前未被描述的HLA等位基因,被指定为HLA-C*14:159.
- 这种新型单基因在移植评估的背景下被确定.
- 该等位基因的独特序列通过严格的类型确定得到证实.
结论:
- 鉴定HLA-C*14:159扩大了已知的HLA等位基因库.
- 这一发现强调了持续的HLA类型鉴定对于供体与受体匹配的重要性.
- 精确的HLA类型,包括新型等位基因,对于优化移植结果至关重要.
关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈HLA-C*14:159 这种蛋白质是什么?韩国 韩国人 韩国人 韩国人下一代测序是下一代的测序.一个新型的等位基因更多相关视频
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.1K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.8K
相关概念视频
03:00Next-generation Sequencing
88.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.7K
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K